Report

Computer-Aided Drug Discovery Market By Type (Structure-Based Drug Design, Sequence-Based Approaches, Ligand-Based Drug Design); By Therapeutic Area (Oncology, Diabetes, Cardiovascular Disease, Neurology, Respiratory Disease, Others); By End-User (Pharmaceutical Companies, Research Laboratories, Biotechnology Companies) Global Opportunity Analysis and Industry Forecast To 2030

  • Publish Date: Jul,2022
  • Report ID: QI038
  • Page : 200
  • Report Type : PDF (Email)
The global computer-aided drug discovery market size was US$ 2,845 million in 2021. The global computer-aided drug discovery market size is forecast to reach US$ 7,232 million by 2030, growing at a compound annual growth rate (CAGR) of 11.3% during the forecast period from 2022 to 2030.

A cutting-edge computational technique used in drug development to find and utilize prospective leads is called computer-aided drug discovery (CADD). Aspects of computer-aided drug design include computational chemistry, molecular modeling, molecular design, and rational drug design. The quality of leads that have been identified is being improved using CADD. CADD techniques are becoming more well-liked and well-accepted in academic and pharmaceutical circles. In the global drug development process, CADD is a useful technique for locating possible medicinal molecules. Since CADD techniques and technologies have the ability to speed up the hit identification, strike to lead, and result enhancement processes, they have been used in nearly every stage of the drug development pipeline.

Factors Influencing Market Growth
The rising frequency of chronic and undiagnosed diseases and rapidly growing occurrence of diabetes and cancer drive the global market.
Rising advancements in pharmaceutical development and developing the application of Machine Learning and Artificial Intelligence boost the global market.
A lack of qualified labor and a shortage of a high-quality biomolecule database may slow down the overall market growth.
Substantial progress in the field of computer-aided drug discovery and technical advances in emerging economies are forecast to offer lucrative opportunities for the global market during the forecast period.

Impact Analysis of COVID-19
The COVID-19 pandemic had a positive impact on the global market. Due to increasing R&D efforts by scientists, researchers, and biotech & biopharmaceutical businesses in order to stop the COVID-19 from spreading. The global search for a cure or medicine to combat this deadly illness has been sparked by the coronavirus's rising rate of transmutation. As a result, the significance of research and drug discovery has increased dramatically, fueling the market's expansion.

Regional Analysis
North America garnered a significant market share in 2021 and is forecast to have substantial growth during the forecast period. As a result of the growing number of cancer patients. Additionally, growing research activities at institutes and hospitals have also installed and elevated their cancer investigation procedures using computer-aided drug discovery.

Leading Competitors
The leading prominent companies profiled in the global computer-aided drug discovery market are:
Charles river laboratories
BOC Sciences
Bioduro-Sundia
Schrdinger, Incorporated
Aragen Life Sciences Pvt. Limited.
Aris Pharmaceuticals, Incorporated
Bayer AG
AstraZeneca plc
Albany Molecular Research Inc. (AMRI)
Other Prominent Players

Scope of the Report
The global computer-aided drug discovery market segmentation focuses on Type, Therapeutic Area, End-User, and Region.
Segmentation based on Type
Structure-Based Drug Design
Sequence-Based Approaches
Ligand-Based Drug Design
Segmentation based on Therapeutic Area
Oncology
Diabetes
Cardiovascular Disease
Neurology
Respiratory Disease
Others
Segmentation based on End-User
Pharmaceutical Companies
Research Laboratories
Biotechnology Companies
Segmentation based on Region
North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America

Meta Title: Computer-Aided Drug Discovery Market Size, Share, Insight and Forecast 2022 To 2030
Meta Description: Global Computer-Aided Drug Discovery Market is projected to reach US$ 7,232 million by the end of 2030 from US$ 2,845 million in 2021, at a CAGR of 11.3%
Meta Keywords: computer-aided drug discovery market Size, computer-aided drug discovery market share, computer-aided drug discovery market trend, computer-aided drug discovery market Forecast, computer-aided drug discovery market insight